Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Al-Qudah, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Qudah, A. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Immunoglobulins in the Treatment of Guillain- Barré Syndrome in Early Childhood

Abdelkarim A. Al-Qudah, MBBS, ABCN

Department of Pediatrics, Jordan University Hospital, Amman, Jordan

This is a prospective study on the use of immunoglobulins in the treatment of Guillain-Barré syndrome in four children, three of whom were younger than 3 years of age. All of them were unable to walk and were still deteriorating when the treatment was started. Three patients started recovering within 24 hours, and all the patients were fully mobile within 6 weeks after receiving first dose of immunoglobulins. This report shows the efficacy of intravenous immunoglobulins in the treatment of young children presenting with acute Guillain-Barré syndrome. (J Child Neurol 1994;9:178-180).

Journal of Child Neurology, Vol. 9, No. 2, 178-180 (1994)
DOI: 10.1177/088307389400900215
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
B. L. Y. Wong and T. A. Glauser
Single High-Dose Intravenous Immunoglobulin for Treatment of Pediatric Guillain-Barre Syndrome
J Child Neurol, March 1, 1998; 13(3): 146 - 146.
[PDF]

Home page
 J Child NeurolHome page
S. A. Abd-Allah, P. W. Jansen, S. Ashwal, and R. M. Perkin
Intravenous Immunoglobulin as Therapy for Pediatric Guillain-Barre Syndrome
J Child Neurol, September 1, 1997; 12(6): 376 - 380.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
A. H. Jackson, G. D. Baquis, and B. L. Shah
Congenital Guillain-Barre Syndrome
J Child Neurol, September 1, 1996; 11(5): 407 - 410.
[PDF]

Home page
 J Child NeurolHome page
M. R. Delgado
Guillain-Barre Syndrome: A Pediatric Challenge
J Child Neurol, January 1, 1996; 11(1): 1 - 3.
[PDF]

Home page
 J Child NeurolHome page
H. R. Jones JR
Topical Review: Childhood Guillain-Barre Syndrome: Clinical Presentation, Diagnosis, and Therapy
J Child Neurol, January 1, 1996; 11(1): 4 - 12.
[Abstract] [PDF]